Loading...
XHKG
0575
Market cap204kUSD
Dec 05, Last price  
1.06HKD
1D
-3.64%
1Q
41.33%
Jan 2017
-91.02%
Name

Endurance RP Ltd

Chart & Performance

D1W1MN
XHKG:0575 chart
P/E
—
P/S
55.27
EPS
—
Div Yield, %
—
Shrs. gr., 5y
19.98%
Rev. gr., 5y
2.74%
Revenues
719k
+88.22%
3,425,0004,175,0003,684,0006,142,00020,553,0005,332,0004,669,0005,890,0002,670,000-10,000212,000137,0005,232,0006,120,000628,0001,320,0002,966,00035,000382,000719,000
Net income
-4m
L-82.11%
-41,892,0008,134,000612,000-160,943,00011,052,00059,792,000-48,527,000-44,854,000-25,636,000-8,563,000-9,333,000-2,460,000-27,359,000-31,087,000-65,999,000-24,396,000-12,598,000-36,427,000-25,049,000-4,482,000
CFO
-4m
L+15.01%
-3,531,000-7,297,000-4,430,000-41,095,000-15,219,000-36,407,000-73,587,000-6,130,00052,654,000-3,984,000-7,732,000-8,307,000-2,747,000-1,882,000-9,038,000-5,721,000-1,703,000545,000-3,590,000-4,129,000
Dividend
Feb 08, 20130.0065 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.
URL
http://www.endurancerp.com/
IPO date
May 19, 1997
Employees
20
Domiciled in
HK
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT